Detection of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) in donor eyes was performed. DNAs were extracted from the uvea, and they were amplified using the polymerase chain reaction (PCR). Amplified viral DNAs were detected with liquid hybridisation and chemiluminescent assay in which no radioactive materials were used. This method was shown to have a sensitivity limit of fewer than 10 copies of HIV, making it much more sensitive than the current techniques employed in eye banks. The method was applied to 120 donor eyes, including four from donors seropositive for HBV. The HBV gene was detected in one case in which the donor's blood had not been tested for HBV. HIV and HCV genes were not detected in any of the samples. The assay could be an effective screening test for the detection of these viruses in eye bank eyes. (BrJ Ophthalmol 1994; 78: 859-862) 
Transmission of viral diseases is one of the potential hazards associated with corneal transplantation. To date, rabies and Creutzfeld-Jakob disease have been reported to be transmitted to recipients through contaminated corneas.l For years, hepatitis B had been suspected as being transmittable and three such cases were reported (Hoft et al, presented as a poster at the American Academy of Ophthalmology Annual Meeting, Las Vegas, NV, 1988). Human immunodeficiency virus (HIV) has also been detected in tears, conjunctiva, and corneas from AIDS patients, although transmission via corneal transplantation has not been documented.5-8 Eye banks in some countries recommend examination ofdonor blood for HIV antibody, hepatitis B virus (HBV) antigen, and hepatitis C virus (HCV) antibody. However, the current screening method has some drawbacks. Firstly, donor blood, which is taken by cardiac, femoral, or subclavian puncture, is necessary for the detection.9 This procedure may be distasteful or unacceptable to family members, especially in Buddhist countries such as Japan. Secondly, false negative results are sometimes inevitable for antibody detection such as HIV. We developed highly sensitive and specific detection systems for infections with HBV, HIV, and HCV to overcome these problems. The polymerase chain reaction (PCR) method was used for this purpose. Application of the method to eye bank eyes is discussed. Table 1 . Each primer (100 pmol) was added per reaction. The temperature was set at 94°C during denaturation (1 minute), 55°C during annealing (2 minutes), and 72°C during polymerisation (2 minutes) on an automated thermal cycler (Perkin-ElmerCetus, Norwalk, CT, USA). The cycles were repeated 40 times, then the reaction was discontinued by keeping the sample at 72°C for 10 minutes. As control of PCR of genomic DNA, a 1000 base pair fragment of human 1 actin DNA was amplified by the DNA/PCR method using B actin primer pair (Clontech Laboratories Inc, Palo Alto, CA, USA).
DETECTION OF THE VIRUS DNA
The viral DNAs were detected from the PCR Detection ofhuman immunodeficiency virus, hepatitis B virus, and hepatitis C virus in donor eyes using polymerase chain reaction ured by liquid hybridisation, agarose gel electrophoresis, pressure transfer to nylon membrane, ultraviolet cross linking, and chemiluminescence assay (Fig 1) . The integrated system allowed the detection of viral DNA in 3 hours. With the rapid system, the sensitivity of the assay was examined using the diluted cell suspensions. The limitation ofdetection was found to be fewer than two cells, which corresponded to about eight copies of HIV DNA detected by using plasmid DNA of HIV PBH10 R3 (Fig 1) . Further, we detected low numbers of the viral DNA copies (range 6-9) by HBV DNA-PCR of pSHB3 provided by Dr T Matsubara, Osaka University, Osaka (Fig 2) . HCV DNA-PCR was also devised to assay for HCV provirus of eye tissue; HCV DNA was seen with as few as four to six copies of proviral DNA (Fig 2) .
DETECTION OF HIV, HBV, AND HCV FROM DONOR EYES
Chemiluminescence analysis of DNA samples of donor eyes from 120 individuals revealed that one amplified DNA sample was positive for the HBV gene (data not shown). To assess the HBV DNA of the tissue, amplified HBV DNA was digested with BamHI, followed by agarose gel electrophoresis. Two digested products were generated with BamHI treatment from the HBV DNA-PCR positive eye (Fig 3, lane 1) , but not from the negative eyes (Fig 3, lanes 2 and 3) 
